How to adjust insulin for a patient on morning Mixtard (NPH insulin and regular insulin) and hydrocortisone, experiencing afternoon hypoglycemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adjusting Insulin for Afternoon Hypoglycemia on Morning Mixtard and Hydrocortisone

Reduce the morning NPH component of Mixtard by 10-20% to address the afternoon hypoglycemia, as the NPH peaks 4-6 hours after administration and is causing excessive insulin action when steroid effect is waning. 1, 2

Understanding the Problem

  • Morning-administered NPH insulin peaks at 4-6 hours after injection, which corresponds to afternoon timing 2
  • Hydrocortisone administered in the morning creates a characteristic glycemic pattern with normal/mild fasting hyperglycemia, increasing hyperglycemia during the afternoon, and peaking in the evening 1
  • The mismatch occurs because NPH peaks in the afternoon while the steroid's hyperglycemic effect is still building, creating a window of relative insulin excess 1, 2

Specific Adjustment Protocol

Immediate action:

  • Reduce the NPH component of the morning Mixtard dose by 10-20% 1, 2
  • If hypoglycemia recurs without clear cause, reduce by an additional 10-20% 1, 2
  • Keep the regular insulin component unchanged initially, as it addresses breakfast coverage 1

Monitoring strategy:

  • Check blood glucose every 2-4 hours for the first 24-48 hours after adjustment to identify patterns 2
  • Target afternoon glucose of 140-180 mg/dL 2
  • Watch specifically for the 2-6 PM window when NPH peaks 2

Alternative Regimen Considerations

If hypoglycemia persists despite dose reduction:

  • Consider splitting to a twice-daily NPH regimen (2/3 morning, 1/3 evening) rather than using Mixtard 1, 2
  • This allows independent adjustment of morning and evening NPH doses 1
  • The conversion would use 80% of current total NPH dose, distributed as 2/3 before breakfast and 1/3 before dinner 1, 3

For steroid-induced hyperglycemia management:

  • The morning NPH dose specifically targets the afternoon-to-evening hyperglycemic peak caused by hydrocortisone 2, 4
  • However, if the steroid dose is being tapered, NPH requirements decrease proportionally (typically 10-20% reduction per significant steroid decrease) 2, 4

Common Pitfalls to Avoid

  • Do not reduce the regular insulin component first - afternoon hypoglycemia indicates NPH excess, not prandial insulin excess 1, 2
  • Do not wait to adjust - prior hypoglycemia blunts counterregulatory responses to subsequent episodes, increasing risk of severe hypoglycemia 1, 5
  • Do not assume the problem is dietary - the pharmacokinetic mismatch between NPH peak and steroid effect is the primary issue 1, 2
  • Avoid unit-for-unit conversions if switching insulin types - always use the 80% rule when converting from long-acting to NPH 1, 3

Coordination with Hydrocortisone Timing

  • Ensure hydrocortisone is administered in the morning to match the NPH timing 2, 4
  • If hydrocortisone is given in divided doses, the larger portion should be in the morning 2
  • As hydrocortisone dose changes, reassess NPH requirements every 3 days 2

Special Considerations for Mixtard Users

  • Mixtard combines NPH and regular insulin in fixed ratios (typically 70/30 or 50/50) 1
  • Reducing the total Mixtard dose affects both components proportionally 1
  • If independent adjustment of basal and prandial components is needed, transition to separate insulin formulations 1
  • Some patients may benefit from switching to a self-mixed regimen where NPH and short-acting insulins can be adjusted separately 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Steroid-Induced Hyperglycemia with NPH Insulin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Insulin Conversion from Lantus to NPH

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hyperglycemia in Post-Kidney Transplant Patients on High-Dose Steroids

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

How do you instruct an adult patient with type 2 diabetes to titrate Lantus (insulin glargine) for blood sugar management?
How to titrate insulin glargine (long-acting insulin) for a patient with hyperglycemia (elevated blood glucose levels)?
What is the recommended initial dosing regimen for a patient with diabetes who requires twice-daily (2 times a day) insulin dosing, specifically using NPH (Neutral Protamine Hagedorn) insulin?
At what dose of long-acting (LA) insulin should it be split into two daily doses?
Can a patient with type 2 diabetes (T2D) taking metformin, vildagliptin (galvus), and regular insulin, who requires 40 units of glargine, receive it in divided doses twice daily?
What is the recommended management for a patient with nasopharyngeal cancer presenting with Trotter's triad (a combination of symptoms including trigeminal neuralgia, soft palate immobility, and conductive hearing loss)?
What is the best treatment approach for a pregnant woman with two episodes of loose stools and stable vital signs?
Is vascular dementia associated with parkinsonism in older adults with a history of cerebrovascular disease?
What is the diagnostic approach for a female patient of reproductive age presenting with unilateral polycystic ovary syndrome (PCOS)?
What is the recommended treatment for a patient presenting with epistaxis (nosebleed)?
What is the post-operative care for an adult patient with a history of perianal disease, who underwent a surgical procedure to treat a transsphincteric fistula involving less than 30% of the external anal sphincter complex?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.